Takeda Pharmaceuticals has released a letter in support of the 340B Program. Click here to read it.

Biogen Idec has released a letter in support of the 340B Program. Click here to read it.

National Hemophilia Foundation has released a letter in support of the 340B Program. Click here to read it.

Pfizer has released a letter in support of the 340B Program. Click here to read it.

Novo Nordisk has released a letter in support of the 340B Program. Click here to read it.

CSL Behring has released a letter in support of the 340B Program. Click here to read it.

Grifols has released a letter in support of the 340B Program. Click here to read it.

Bioverativ has released a letter in support of the 340B Program. Click here to read it.

Aptevo Therapeutics has released a letter in support of the 340B Program. Click here to read it.

Octapharma has released a letter in support of the 340B Program. Click here to read it.